Suminori Kono Selected Research

Glycated Hemoglobin (Glycosylated Hemoglobin)

4/2010	Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women.
6/2008	A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suminori Kono Research Topics

Disease

26	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 01/2002
14	Carcinogenesis 05/2014 - 11/2002
13	Adenoma (Adenomas) 07/2013 - 11/2002
12	Type 2 Diabetes Mellitus (MODY) 04/2020 - 12/2002
7	Colonic Neoplasms (Colon Cancer) 01/2015 - 12/2004
7	Glucose Intolerance 06/2013 - 12/2002
7	Neoplasms (Cancer) 08/2012 - 08/2002
6	Diabetes Mellitus 05/2017 - 01/2003
6	Inflammation (Inflammations) 02/2012 - 04/2007
6	Obesity 06/2010 - 01/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 10/2005
5	Myocardial Infarction 02/2011 - 01/2002
4	Hypercholesterolemia 01/2024 - 05/2004
4	Rectal Neoplasms (Rectal Cancer) 01/2015 - 12/2004
4	Hypertension (High Blood Pressure) 02/2012 - 05/2004
4	Coronary Disease (Coronary Heart Disease) 11/2010 - 06/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 10/2022
2	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 03/2017
2	Overweight 01/2012 - 11/2002
2	Osteoporosis 04/2010 - 09/2009
2	Insulin Resistance 06/2008 - 11/2006
2	Abdominal Obesity 04/2008 - 10/2005
2	Cerebral Infarction 01/2005 - 06/2003
1	Chronic Disease (Chronic Diseases) 10/2022
1	Parkinson Disease (Parkinson's Disease) 10/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022
1	Cognitive Dysfunction 03/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Polyps 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Carotid Artery Diseases 01/2014
1	Atherosclerosis 01/2014

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 04/2020 - 11/2002
8	LipidsIBA 01/2024 - 06/2003
8	CalciumIBA 01/2015 - 07/2005
8	EnzymesIBA 07/2013 - 12/2004
7	CholesterolIBA 01/2024 - 06/2003
7	Coffee FDA Link 06/2013 - 01/2010
7	HDL CholesterolIBA 01/2013 - 05/2004
7	Folic Acid (Vitamin M)FDA LinkGeneric 01/2013 - 02/2003
5	C-Reactive ProteinIBA 02/2012 - 04/2007
5	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 09/2005 - 02/2003
4	LDL CholesterolIBA 01/2024 - 06/2008
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 04/2009
4	TeaIBA 05/2017 - 04/2010
4	Pravastatin (Pravachol)FDA LinkGeneric 01/2014 - 06/2006
3	Ezetimibe (Zetia)FDA Link 01/2024 - 01/2012
3	Triglycerides (Triacylglycerol)IBA 01/2017 - 10/2005
3	Vitamin D FDA LinkGeneric 01/2015 - 10/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014 - 01/2005
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2013 - 04/2007
3	IsoflavonesIBA 02/2013 - 01/2002
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2013 - 04/2007
3	Atorvastatin (Lipitor)FDA Link 01/2013 - 06/2006
3	BilirubinIBA 02/2011 - 04/2010
3	DNA (Deoxyribonucleic Acid)IBA 07/2010 - 11/2004
2	PlasmalogensIBA 10/2022 - 03/2017
2	Dietary CalciumIBA 01/2015 - 01/2013
2	8-hydroxyguanineIBA 01/2014 - 07/2010
2	pitavastatin (itavastatin)FDA Link 01/2014 - 06/2008
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 07/2013 - 06/2010
2	CarcinogensIBA 07/2013 - 01/2009
2	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 01/2013 - 10/2012
2	oxidized low density lipoproteinIBA 01/2013 - 06/2008
2	CarbonIBA 01/2013 - 10/2012
2	Thymidylate SynthaseIBA 01/2013 - 10/2012
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 10/2012 - 01/2003
2	Oxidoreductases (Dehydrogenase)IBA 10/2012 - 12/2004
2	AntioxidantsIBA 08/2012 - 04/2010
2	Caffeine (No Doz)FDA LinkGeneric 01/2012 - 05/2010
2	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2011 - 08/2007
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2010 - 01/2003
2	Alanine Transaminase (SGPT)IBA 04/2010 - 01/2003
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2010 - 06/2008
2	Protein Isoforms (Isoforms)IBA 02/2009 - 03/2008
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2009 - 07/2008
2	Aldehyde DehydrogenaseIBA 08/2007 - 08/2005
2	Bile Acids and Salts (Bile Acids)IBA 05/2006 - 04/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 11/2002 - 08/2002
2	Insulin-Like Growth Factor Binding Protein 3IBA 11/2002 - 08/2002
1	campesterolIBA 01/2024
1	Phytosterols (Plant Sterols)IBA 01/2024
1	phosphatidal ethanolaminesIBA 10/2022
1	Phosphatidylcholines (Phosphatidylcholine)IBA 10/2022
1	Sitagliptin Phosphate (Januvia)FDA Link 04/2020
1	ApolipoproteinsIBA 04/2020
1	Fenofibrate (CiL)FDA LinkGeneric 01/2017
1	methyl 4-azidophenylacetimidate (APAI)IBA 01/2015
1	AminesIBA 01/2015
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2015
1	SugarsIBA 05/2014
1	Sucrose (Saccharose)IBA 05/2014
1	Protective AgentsIBA 01/2014
1	Epoxide HydrolasesIBA 08/2013
1	PolyphenolsIBA 05/2013
1	Estrogen ReceptorsIBA 02/2013

Therapy/Procedure

2	Therapeutics 01/2017 - 07/2010
2	Percutaneous Coronary Intervention 10/2004 - 11/2002
2	Stents 10/2004 - 05/2003
1	Oral Administration 03/2017